Volgen
Peter Rebeiro
Peter Rebeiro
Assistant Professor, Vanderbilt University School of Medicine
Geverifieerd e-mailadres voor vanderbilt.edu - Homepage
Titel
Geciteerd door
Geciteerd door
Jaar
Greater weight gain in treatment-naive persons starting dolutegravir-based antiretroviral therapy
K Bourgi, PF Rebeiro, M Turner, JL Castilho, T Hulgan, SP Raffanti, ...
Clinical Infectious Diseases 70 (7), 1267-1274, 2020
2842020
Brief report: weight gain in persons with HIV switched from efavirenz-based to integrase strand transfer inhibitor–based regimens
J Norwood, M Turner, C Bofill, P Rebeiro, B Shepherd, S Bebawy, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 76 (5), 527-531, 2017
2792017
Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large …
K Bourgi, CA Jenkins, PF Rebeiro, BE Shepherd, F Palella, RD Moore, ...
Journal of the International AIDS Society 23 (4), e25484, 2020
1862020
End-stage renal disease among HIV-infected adults in North America
AG Abraham, KN Althoff, Y Jing, MM Estrella, MM Kitahata, CW Wester, ...
Clinical Infectious Diseases 60 (6), 941-949, 2015
1732015
Multimorbidity among persons living with human immunodeficiency virus in the United States
C Wong, SJ Gange, RD Moore, AC Justice, K Buchacz, AG Abraham, ...
Clinical Infectious Diseases 66 (8), 1230-1238, 2018
1722018
Incidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV-infected persons in the United States and Canada, 2000–2010
K Buchacz, B Lau, Y Jing, R Bosch, AG Abraham, MJ Gill, MJ Silverberg, ...
The Journal of infectious diseases 214 (6), 862-872, 2016
1712016
Retention among North American HIV-infected persons in clinical care, 2000–2008
P Rebeiro, KN Althoff, K Buchacz, J Gill, M Horberg, H Krentz, R Moore, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 62 (3), 356-362, 2013
1692013
Oxidant stress is increased during treatment of human immunodeficiency virus infection
T Hulgan, J Morrow, RT D'Aquila, S Raffanti, M Morgan, P Rebeiro, ...
Clinical Infectious Diseases 37 (12), 1711-1717, 2003
1582003
US trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008
KN Althoff, K Buchacz, HI Hall, J Zhang, DB Hanna, P Rebeiro, SJ Gange, ...
Annals of internal medicine 157 (5), 325-335, 2012
1362012
Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care
DC Lemly, BE Shepherd, T Hulgan, P Rebeiro, S Stinnette, RB Blackwell, ...
The Journal of infectious diseases 199 (7), 991-998, 2009
1342009
Drug transporter and metabolizing enzyme gene variants and nonnucleoside reverse-transcriptase inhibitor hepatotoxicity
MD Ritchie, DW Haas, AA Motsinger, JP Donahue, H Erdem, S Raffanti, ...
Clinical Infectious Diseases 43 (6), 779-782, 2006
1292006
Impact of age on retention in care and viral suppression
BR Yehia, P Rebeiro, KN Althoff, AL Agwu, MA Horberg, H Samji, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 68 (4), 413-419, 2015
1102015
Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy
JH Tai, MA Udoji, G Barkanic, DW Byrne, PF Rebeiro, BR Byram, ...
The Journal of infectious diseases 196 (7), 1044-1052, 2007
1092007
Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001–2009
DB Hanna, K Buchacz, KA Gebo, NA Hessol, MA Horberg, LP Jacobson, ...
Clinical Infectious Diseases 56 (8), 1174-1182, 2013
1082013
CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts> 350 lymphocytes/mm3
T Hulgan, S Raffanti, A Kheshti, RB Blackwell, PF Rebeiro, G Barkanic, ...
The Journal of infectious diseases 192 (6), 950-957, 2005
882005
Cancer-attributable mortality among people with treated human immunodeficiency virus infection in North America
EA Engels, EL Yanik, W Wheeler, MJ Gill, MS Shiels, R Dubrow, ...
Clinical Infectious Diseases 65 (4), 636-643, 2017
842017
Disparities in the quality of HIV care when using US Department of Health and Human Services indicators
KN Althoff, P Rebeiro, JT Brooks, K Buchacz, K Gebo, J Martin, R Hogg, ...
Clinical infectious diseases 58 (8), 1185-1189, 2014
782014
First occurrence of diabetes, chronic kidney disease, and hypertension among North American HIV-infected adults, 2000–2013
C Wong, SJ Gange, K Buchacz, RD Moore, AC Justice, MA Horberg, ...
Clinical Infectious Diseases 64 (4), 459-467, 2017
752017
Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting
CW Wester, JR Koethe, BE Shepherd, SE Stinnette, PF Rebeiro, AM Kipp, ...
Aids 25 (12), 1471-1479, 2011
742011
Risk of incident diabetes mellitus, weight gain, and their relationships with integrase inhibitor–based initial antiretroviral therapy among persons with human immunodeficiency …
PF Rebeiro, CA Jenkins, A Bian, JE Lake, K Bourgi, RD Moore, ...
Clinical Infectious Diseases 73 (7), e2234-e2242, 2021
692021
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20